Bausch + Lomb
NYSE
Bausch + Lomb's latest marketcap:
As of 06/07/2025, Bausch + Lomb's market capitalization has reached $4.13 B. According to our data, Bausch + Lomb is the 3728th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 4.13 B |
| Revenue (ttm) | 4.83 B |
| Net Income (ttm) | -362,000,000 |
| Shares Out | 353.4 M |
| EPS (ttm) | -1.03 |
| Forward PE | 16.82 |
| Ex-Dividend Date | n/a |
| Earnings Date | 07/30/2025 |
Bausch + Lomb's yearly market capitalization.
| Date | Market Cap | Change (%) |
|---|---|---|
| 06/07/2025 | $4.13 B | -36.05% |
| 12/31/2024 | $6.36 B | 6.25% |
| 12/29/2023 | $5.99 B | 10.27% |
| 12/30/2022 | $5.43 B |
Company Profile
About Bausch + Lomb Corporation
Bausch + Lomb Corporation is a global eye health company operating in the United States, Puerto Rico, China, France, Japan, Germany, the United Kingdom, Canada, Russia, Spain, Italy, Mexico, Poland, and other international markets.
Business Segments
- Vision Care: Offers a wide range of contact lenses, including daily disposable and therapeutic lenses, along with lens care products, eye vitamins, and over-the-counter eye drops for conditions like allergies, dry eye, and redness relief.
- Pharmaceuticals: Provides proprietary and generic pharmaceutical products for post-operative treatments, glaucoma, ocular hypertension, retinal diseases, and other eye-related conditions.
- Surgical: Supplies medical devices, intraocular lenses, phacoemulsification equipment, and surgical instruments for cataract, corneal, vitreous, and retinal treatments.
Distribution & Operations
The company distributes its products through direct sales teams and independent distributors, ensuring broad market reach.
Company Background
Founded in 1853, Bausch + Lomb Corporation is headquartered in Vaughan, Canada, and operates as a subsidiary of Bausch Health Companies Inc.
Frequently Asked Questions
-
What is Bausch + Lomb's (BLCO) current market cap?As of 06/07/2025, Bausch + Lomb (including the parent company, if applicable) has an estimated market capitalization of $4.13 B USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does Bausch + Lomb (BLCO) rank globally by market cap?Bausch + Lomb global market capitalization ranking is approximately 3728 as of 06/07/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.